In the first update since 2007, the World Health Organization (WHO) offers a new integrated classification of tumors of the central nervous system. The 2016 World Health Organization Classification of Tumors of the Central Nervous System uses molecular parameters in addition to histology to define many tumor entities, ushering in a new era of brain tumor diagnosis and treatment. The hope is that this revised classification will facilitate new studies and ultimately lead to improvements in the lives of patients with brain tumors.
Continue reading »
Harnessing the power of the human immune system, Duke University is blazing a 21st century trail that may just offer the big leap forward in cancer treatment that we have been hoping to achieve since the advent of radiation therapy in the late 19th century.
Learn more >> http://www.cbsnews.com/news/polio-cancer-treatment-duke-university-60-minutes-scott-pelley/
Within moments of speaking with Isaac Yang, MD, it is clear he has excitement and passion for patients and patient education. Dr. Yang, a neurosurgeon specializing in the surgical treatment and clinical outcomes of adult brain tumors at UCLA, is an active advocate for patient education and provides many educational resources to empower patients and help them understand their treatment options.
Brainlab.org had the chance to sit down with Dr. Yang to learn more about his passion for helping patients with brain tumors, providing credible resources to educate them through their treatment process and using Brainlab technology.
Continue reading »
This year, Brainlab sponsored the 2016 Chicago BT5K Breakthrough for Brain Tumors Run & Walk, the American Brain Tumor Association’s signature fundraising program. This year, the ABTA is hosting 5K events in eight states with the goal of raising $2 million for brain tumor research, patient programs and support services.
Continue reading »
There is another promising study linking cancer treatment with our immune system.
Continue reading »
